Cargando…

Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis

BACKGROUND: Increased elastase activity in α(1)-antitrypsin deficiency may affect elasticity of the arterial walls, and thereby blood pressure and susceptibility to cardiovascular disease. We hypothesized that severe α(1)-antitrypsin deficiency is associated with reduced blood pressure and susceptib...

Descripción completa

Detalles Bibliográficos
Autores principales: Winther, Sine Voss, Ahmed, Dunia, Al-Shuweli, Suzan, Landt, Eskild Morten, Nordestgaard, Børge Grønne, Seersholm, Niels, Dahl, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905778/
https://www.ncbi.nlm.nih.gov/pubmed/35264159
http://dx.doi.org/10.1186/s12931-022-01973-3
_version_ 1784665264573382656
author Winther, Sine Voss
Ahmed, Dunia
Al-Shuweli, Suzan
Landt, Eskild Morten
Nordestgaard, Børge Grønne
Seersholm, Niels
Dahl, Morten
author_facet Winther, Sine Voss
Ahmed, Dunia
Al-Shuweli, Suzan
Landt, Eskild Morten
Nordestgaard, Børge Grønne
Seersholm, Niels
Dahl, Morten
author_sort Winther, Sine Voss
collection PubMed
description BACKGROUND: Increased elastase activity in α(1)-antitrypsin deficiency may affect elasticity of the arterial walls, and thereby blood pressure and susceptibility to cardiovascular disease. We hypothesized that severe α(1)-antitrypsin deficiency is associated with reduced blood pressure and susceptibility to cardiovascular disease. METHODS: We genotyped 91,353 adults randomly selected from the Danish general population and 187 patients from the Danish α(1)-Antitrypsin Deficiency Registry and recorded baseline blood pressure, baseline plasma lipids and cardiovascular events during follow-up. 185 participants carried the ZZ genotype, 207 carried the SZ genotype and 91,148 carried the MM genotype. RESULTS: α(1)-Antitrypsin deficiency was associated with decreases in blood pressure of up to 5 mmHg for systolic blood pressure and up to 2 mmHg for diastolic blood pressure, in ZZ vs SZ vs MM individuals (trend test, P’s ≤ 0.01). Plasma triglycerides and remnant cholesterol were reduced in ZZ individuals compared with MM individuals (t-test, P’s < 0.001). α(1)-Antitrypsin deficiency was associated with lower risk of myocardial infarction (trend test P = 0.03), but not with ischemic heart disease, ischemic cerebrovascular disease or hypertension (trend test, P’s ≥ 0.59). However, when results for ischemic heart disease were summarized in meta-analysis with results from four previous studies, individuals with versus without α(1)-antitrypsin deficiency had an odds ratio for ischemic heart disease of 0.66 (95% CI:0.53–0.84). CONCLUSIONS: Individuals with severe α(1)-antitrypsin deficiency have lower systolic and diastolic blood pressure, lower plasma triglycerides and remnant cholesterol, reduced risk of myocardial infarction, and a 34% reduced risk of ischemic heart disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-01973-3.
format Online
Article
Text
id pubmed-8905778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89057782022-03-18 Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis Winther, Sine Voss Ahmed, Dunia Al-Shuweli, Suzan Landt, Eskild Morten Nordestgaard, Børge Grønne Seersholm, Niels Dahl, Morten Respir Res Research BACKGROUND: Increased elastase activity in α(1)-antitrypsin deficiency may affect elasticity of the arterial walls, and thereby blood pressure and susceptibility to cardiovascular disease. We hypothesized that severe α(1)-antitrypsin deficiency is associated with reduced blood pressure and susceptibility to cardiovascular disease. METHODS: We genotyped 91,353 adults randomly selected from the Danish general population and 187 patients from the Danish α(1)-Antitrypsin Deficiency Registry and recorded baseline blood pressure, baseline plasma lipids and cardiovascular events during follow-up. 185 participants carried the ZZ genotype, 207 carried the SZ genotype and 91,148 carried the MM genotype. RESULTS: α(1)-Antitrypsin deficiency was associated with decreases in blood pressure of up to 5 mmHg for systolic blood pressure and up to 2 mmHg for diastolic blood pressure, in ZZ vs SZ vs MM individuals (trend test, P’s ≤ 0.01). Plasma triglycerides and remnant cholesterol were reduced in ZZ individuals compared with MM individuals (t-test, P’s < 0.001). α(1)-Antitrypsin deficiency was associated with lower risk of myocardial infarction (trend test P = 0.03), but not with ischemic heart disease, ischemic cerebrovascular disease or hypertension (trend test, P’s ≥ 0.59). However, when results for ischemic heart disease were summarized in meta-analysis with results from four previous studies, individuals with versus without α(1)-antitrypsin deficiency had an odds ratio for ischemic heart disease of 0.66 (95% CI:0.53–0.84). CONCLUSIONS: Individuals with severe α(1)-antitrypsin deficiency have lower systolic and diastolic blood pressure, lower plasma triglycerides and remnant cholesterol, reduced risk of myocardial infarction, and a 34% reduced risk of ischemic heart disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-01973-3. BioMed Central 2022-03-09 2022 /pmc/articles/PMC8905778/ /pubmed/35264159 http://dx.doi.org/10.1186/s12931-022-01973-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Winther, Sine Voss
Ahmed, Dunia
Al-Shuweli, Suzan
Landt, Eskild Morten
Nordestgaard, Børge Grønne
Seersholm, Niels
Dahl, Morten
Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
title Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
title_full Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
title_fullStr Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
title_full_unstemmed Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
title_short Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
title_sort severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905778/
https://www.ncbi.nlm.nih.gov/pubmed/35264159
http://dx.doi.org/10.1186/s12931-022-01973-3
work_keys_str_mv AT winthersinevoss severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis
AT ahmeddunia severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis
AT alshuwelisuzan severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis
AT landteskildmorten severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis
AT nordestgaardbørgegrønne severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis
AT seersholmniels severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis
AT dahlmorten severea1antitrypsindeficiencyassociatedwithlowerbloodpressureandreducedriskofischemicheartdiseaseacohortstudyof91540individualsandametaanalysis